Have you ever thought about taking part in a Medical Trial? By registering your details with MedTrials.co.uk, we are able to send your details directly to companies who are looking for volunteers to take part in their medical research studies.
Information about you is kept on a register that CROs, Pharmaceutical companies and Clinical Investigators can access to contact you regarding individual studies.
MedTrials.co.uk is a website that will put you in direct contact with Pharmaceutical Companies, CRO’s (Clinical Research Organisations) and Clinical Investigators that are running Phase I (1) and Phase II (2) clinical trials.
Medical trials are an integral part of the drug development process. Patient and volunteer participation is vital for continued medical research and these trials are carried out under strict regulations.
If at any point you feel that you have changed your mind and are no longer interested in undertaking a medical trial you can unsubscribe from our service. If you are already part way through a medical trial, speak to the Clinical Investigator and they will advise you of your options.
Clinical research companies often offer financial compensation for your time and expenses.
A study from members of the research team investigating whether increasing blood levels of the antioxidant urate can slow the progression of Parkinson’s disease has found that the neuroprotective… Go to Source
Repatha is the second in a class of drugs to be approved by the FDA that addresses how the liver performs in relation to the treatment of high cholesterol. Go to Source
TiGenix NV, an advanced biopharmaceutical company focused on developing and commercialising novel therapeutics from its proprietary platforms of allogeneic expanded stem cells, has announced that… Go to Source
Pivotal, global phase III study results for Fycompa® (perampanel) in primary generalised tonic-clonic (PGTC) seizures are published for the first time today in Neurology. Go to Source
Researchers find a daily dose of the diabetes drug liraglutide may lead to substantial weight loss for people with type 2 diabetes who are overweight or obese. Go to Source
The FDA have approved the first ever drug to treat low sexual desire in premenopausal women. Flibanserin – brand name Addyi – will be available from mid-October. Go to Source